# Ebanga

NDC: 71655-578
Generic name: Ansuvimab
Labeler / Manufacturer: Emergent Manufacturing Operations Baltimore, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20201221

FDA application: BLA761172

## Active ingredients

- ANSUVIMAB: 400 mg/8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71655-578"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71655-578
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5